Expensify (EXFY) Research & Development (2020 - 2026)

Expensify has disclosed Research & Development across 7 years of filings, most recently posting $5.3 million for Q1 2026.

• Research & Development for Q1 2026 came in at $5.3 million, down 1.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.6 million (down 14.45% YoY), and the FY2025 annual result was $20.7 million, down 16.05% from the prior year.
• Research & Development came in at $5.3 million for Q1 2026 at Expensify, roughly flat from $5.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $6.7 million in Q4 2024 to a low of $3.0 million in Q4 2022.
• The 5-year median for Research & Development is $5.3 million (2026), against an average of $5.2 million.
• Peak annual rise in Research & Development reached 237.37% in 2022, while the deepest fall reached 26.47% in 2022.
• Expensify's Research & Development stood at $3.0 million in 2022, then jumped by 108.93% to $6.2 million in 2023, then rose by 7.25% to $6.7 million in 2024, then decreased by 21.49% to $5.3 million in 2025, then grew by 0.06% to $5.3 million in 2026.
• The last three Research & Development figures came in at $5.3 million (Q1 2026), $5.3 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.